A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

NCT06322667 · clinicaltrials.gov ↗

RECRUITING

Status

5000

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

OTHER: No Intervention

Sponsor

Eisai Co., Ltd.